Literature DB >> 24422755

Duodenal mucosal damage is associated with proliferative activity of Brunner's gland hamartoma: a case report.

Mayumi Akaki1, Shoji Taniguchi, Kinta Hatakeyama, Ryoji Kushima, Hiroaki Kataoka.   

Abstract

BACKGROUND: Brunner's gland hamartoma is a rare tumor, predominantly found in the fifth to sixth decades of life. Generally, it is a single pedunculated polyp, rarely larger than 5 cm. Asymptomatic cases are found incidentally, but cases with a large polyp tend to have gastrointestinal bleeding and/or obstructive symptoms. Polyp size increases in a time-dependent manner, however, the growth mechanism is unknown. We report a Japanese male case in his mid-twenties with an over 6 cm sized polyp. CASE
PRESENTATION: A 26-year-old man presented black stools and anemia. Endoscopic examination revealed a large pedunculated polyp at gastroduodenal junction. The polyp, subsequently resected by distal gastrectomy, was lobulated with random surface erosions and sized 6.4 × 3 cm. Histological examination revealed that the polyp arose from duodenal mucosa and was composed of hyperplastic Brunner's glands in lobules separated by fibromuscular septa, associated with lymphocytic infiltrate and lymphoid follicles. No evidence of malignancy was found. Thus, the lesion was diagnosed as Brunner's gland hamartoma. Further immunohistochemical studies indicated that gastric foveolar metaplasia is associated with surface epithelium covering upper two thirds of the polyp, showing immunohistochemical positivity for mucin 5 AC (MUC5AC). Below the metaplastic surface epithelium, Brunner's glands had high proliferative activity (MIB-1 labeling index: 7.9%). The similar staining pattern was observed at surface erosive sites (MIB-1 labeling index in Brunner's glands: 9%). On the other hand, surface epithelium in the lower side of the polyp still preserved intestinal nature, containing CDX2-positive nuclei and MUC2-positive goblet cells. Brunner's glands below the surface epithelium with intestinal characteristics showed low proliferative activity (MIB-1 labeling index: 0.77%).
CONCLUSION: Proliferative activity of Brunner's glands was high at the sites with surface erosion and also below the epithelium showing gastric foveolar metaplasia. As gastric foveolar metaplasia occurs along with a mucosal repair process in the duodenum, mucosal damages underlay the hamartomatous proliferation of Brunner's glands and eventually resulted in a formation of large polypoid mass in this case.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24422755      PMCID: PMC3898372          DOI: 10.1186/1471-230X-14-14

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


Background

Brunner’s gland hamartoma is a rare tumor-like lesion, predominantly seen in the fifth to sixth decades of life. This lesion is generally a single pedunculated polyp, with an average size of 2 cm, rarely larger than 5 cm, and locates in the first portion of duodenum [1]. Its pathogenesis is unknown and malignant change is rarely observed [2]. Most cases are asymptomatic and found incidentally. Cases with a large-sized polyp tend to have gastrointestinal bleeding and/or obstructive symptoms. According to studies with long-term follow-up, polyp size gradually increases in a time-dependent manner [3,4]. We experienced a 26 year-old male case with an over 6 cm sized polyp at gastroduodenal junction, investigated histological and immunohistochemical characteristics of the lesion, and report here.

Case presentation

A 26-year-old man presented black stools and anemia. He had not taken any medication and had no specific family or past medical history. His height and weight were 172.3 cm and 93.4 kg (the body mass index was 31.5 kg/m2). His body temperature was 36.7°C, blood pressure was 137/77 mmHg and radial pulse rate was 80 beats/min and regular. Complete blood count showed the red blood cell count of 326 × 104/μl, hemoglobin concentration of 8.6 g/dl (reference range: 13.5 to 17.6 g/dl), and mean corpuscular volume of 87 fl. Serum chemistry showed that hemoglobin A1c was 4.2% (National Glycohemoglobin Standardization Program number). Endoscopic examination of the upper digestive tract revealed a large pedunculated polyp arising from gastroduodenal junction, close to pyloric ring on the side between minor curvature and anterior wall (Figure  1A). The head of the polyp was incarcerated toward duodenal lumen. The lower side of the polyp showed hemorrhage in part. The stalk was too thick to be removed by endoscopic mucosal resection. Instead, distal gastrectomy with lymph node dissection was performed. No metastasis was found in the dissected lymph nodes.
Figure 1

Endoscopic image and gross findings. (A) Endoscopic image showing a large polyp at gastroduodenal junction. The polyp head was incarcerated toward duodenal lumen. Hemorrhage was noted in part of the surface. (B) Surgically resected specimen showing a single lobulated and pedunculated polyp. Hemorrhage and erosion are associated. (C) Cut surface of the polyp is white and solid showing lobular structure and a broad fibrous stalk.

Endoscopic image and gross findings. (A) Endoscopic image showing a large polyp at gastroduodenal junction. The polyp head was incarcerated toward duodenal lumen. Hemorrhage was noted in part of the surface. (B) Surgically resected specimen showing a single lobulated and pedunculated polyp. Hemorrhage and erosion are associated. (C) Cut surface of the polyp is white and solid showing lobular structure and a broad fibrous stalk. The postoperative period was uneventful that the hemoglobin concentration gradually increased and became 11.6 g/dl on day 12. He was subsequently discharged without any complications and was in good health with 1 year follow-up. The surgically resected specimen showed a lobulated polyp sized 6.4 × 3 cm (Figure  1B) and the cut surface was solid and white (Figure  1C). Histologically, the stalk of the polyp projected from duodenal mucosa, not pyloric mucosa. In the lesion, marked proliferation of Brunner’s glands was noted showing lobular structures separated by fibromuscular septa (Figure  2A). Acini and ducts were well preserved (Figure  2C) and cystically dilated ducts were scattered (Figure  2B). Lymphocytic infiltrate was observed in the entire lesion and lymphoid follicle formation was intermingled in and between the lobules of hyperplastic Brunner’s glands (Figure  2B). The upper two thirds of the polyp was covered by a surface epithelium histologically similar to gastric foveolar epithelium (Figure  3A), randomly with surface erosions (Figure  3E). No evidence of malignancy was found within the specimen (Figure  2C). These findings suggested that the lesion was composed of normal tissue elements of duodenal mucosa and submucosa, but formed a disorganized aberrant mass. Thus, we diagnosed this lesion as Brunner’s gland hamartoma. Helicobacter pylori infection was not detected in Giemsa stain.
Figure 2

Histological findings of the resected specimen. (A) Hyperplastic Brunner’s glands in lobules are separated by fibromuscular septa. HE stain, 40× (B) Lymphocytic infiltrate is observed and a lymphoid follicle is formed between lobules of Brunner’s glands at the center. Arrow indicates a cystically dilated duct. HE stain, 40× (C) Acini and ducts are well-preserved without nuclear atypia. HE stain, 200×.

Figure 3

Immunohistochemical findings of the resected specimen. Duodenal mucosa in the upper part of the polyp (A - D), with erosion (E - H), and in the lower part of the polyp (I - L) are shown in HE stain (A, E, and I), MUC5AC (B and F), MUC6 (C and G), MIB-1 (D, H and L), CDX2 (J), and MUC2 (K) immunostains. Surface epithelium in the upper part of the polyp is histologically similar to gastric foveolar epithelium and immunohistochemically positive for MUC5AC, suggesting gastric foveolar metaplasia (B), and the epithelium in the deeper portion and Brunner’s glands are positive for MUC6 (C). This area shows high MIB-1 labeling (D). The similar staining pattern is observed in the mucosa with erosion (E - H). Surface epithelium in the lower part of the polyp shows a villous structure, containing CDX2-positive nuclei (J) and MUC2-positive goblet cells (K), suggesting preservation of the intestinal nature. MIB-1-positive Brunner’s glands are inconspicuous in this area (L). All images are 40× magnification.

Histological findings of the resected specimen. (A) Hyperplastic Brunner’s glands in lobules are separated by fibromuscular septa. HE stain, 40× (B) Lymphocytic infiltrate is observed and a lymphoid follicle is formed between lobules of Brunner’s glands at the center. Arrow indicates a cystically dilated duct. HE stain, 40× (C) Acini and ducts are well-preserved without nuclear atypia. HE stain, 200×. Immunohistochemical findings of the resected specimen. Duodenal mucosa in the upper part of the polyp (A - D), with erosion (E - H), and in the lower part of the polyp (I - L) are shown in HE stain (A, E, and I), MUC5AC (B and F), MUC6 (C and G), MIB-1 (D, H and L), CDX2 (J), and MUC2 (K) immunostains. Surface epithelium in the upper part of the polyp is histologically similar to gastric foveolar epithelium and immunohistochemically positive for MUC5AC, suggesting gastric foveolar metaplasia (B), and the epithelium in the deeper portion and Brunner’s glands are positive for MUC6 (C). This area shows high MIB-1 labeling (D). The similar staining pattern is observed in the mucosa with erosion (E - H). Surface epithelium in the lower part of the polyp shows a villous structure, containing CDX2-positive nuclei (J) and MUC2-positive goblet cells (K), suggesting preservation of the intestinal nature. MIB-1-positive Brunner’s glands are inconspicuous in this area (L). All images are 40× magnification. Then, we sought to clarify the possible pathogenesis of this lesion by immunohistochemical analyses for mucin phenotypes, CDX2 expression and MIB-1 labeling. The surface epithelium resembling gastric foveolar epithelium was positive for MUC5AC (Figure  3B), indicating gastric foveolar metaplasia, while the epithelium in deeper portion and Brunner’s glands were positive for MUC6 (Figure  3C). The epithelial cells at the transition zone between MUC5AC- and MUC6-positive areas showed concomitant expression of MUC5AC and MUC6 (Figure  3B and C). These results confirmed that the surface epithelium differentiated towards gastric foveolar epithelium but preserved intestinal epithelial nature in the deeper portion. Interestingly, the MUC5AC-positive epithelium and adjacent MUC6-positive epithelium were diffusely positive for MIB-1 (Figure  3D), and the Brunner’s glands beneath them showed high MIB-1 labeling index (7.9%; Figures  3D and 4A).
Figure 4

MIB-1 labeling in Brunner’s glands. Representative immunostain images of Brunner’s glands below surface epithelium associated with gastric foveolar metaplasia (A), below erosion (B), and below surface epithelium preserving intestinal nature (C) are shown. Brunner’s glands in (C) are rarely positive for MIB-1, compared to those in (A) and (B). All images are 100× magnification.

MIB-1 labeling in Brunner’s glands. Representative immunostain images of Brunner’s glands below surface epithelium associated with gastric foveolar metaplasia (A), below erosion (B), and below surface epithelium preserving intestinal nature (C) are shown. Brunner’s glands in (C) are rarely positive for MIB-1, compared to those in (A) and (B). All images are 100× magnification. The similar staining pattern was observed in the area with surface erosion (Figure  3E-H), where most of surface epithelium was lost, but the deeper portion of the epithelium was minimally left (Figure  3E), showing MUC5AC/MUC6 double positivity (Figure  3F and 3G) with significantly high MIB-1 labeling (Figure  3H). Moderately high MIB-1 labeling of Brunner’s glands (9%) was accompanied (Figures  3H and 4B). On the other hand, surface epithelium in the lower part of the polyp showed a villous structure containing goblet cells without apparent gastric foveolar metaplasia (Figure  3I). Immunohistochemically, positivity of MUC5AC staining decreased in the lower one third of the polyp, particularly on the distal side. In the same area, CDX2-positive nuclei (Figure  3J) and MUC2-positive goblet cells (Figure  3K) were observed at the surface epithelium showing intestinal nature. Below the surface epithelium preserving intestinal nature, Brunner’s glands had less proliferative activity with low MIB-1 labeling index (0.77%) (Figures  3L and 4C). These results suggest that gastric foveolar differentiation is possibly related with the observed proliferative activity of Brunner’s glands.

Conclusions

Brunner’s gland hamartoma is generally a single pedunculated polyp composed of hyperplastic Brunner’s glands with a variable amount of ducts, smooth muscles, fibrous tissue, adipose tissue, and lymphocytes. This lesion is interchangeably called as Brunner’s gland adenoma, however, some dispute using the latter because this lesion is usually an admixture of normal tissues without cytological atypia. Brunner’s gland hamartoma is predominantly found in those in their fifties to sixties. Several cases in their twenties have been reported with or without describing the lesion size, and to the best of our knowledge, only two cases (23- and 20-year-old women) have been reported mentioning their unusually large polyp size, 5.5 cm examined histologically and 7 cm observed by endoscopy [5,6]. The major disadvantage having a large polyp is that a benign lesion may be misdiagnosed and over-treated as malignancy. In the past, a 60-year-old male case was reported that Brunner’s gland hyperplasia forming a 5.5 cm polyp at duodenal bulb was treated by duodenocephalopancreatectomy [7]. When a large polyp is noted at duodenum, it is important for clinicians to have Brunner’s gland hamartoma as a differential diagnosis, even with the rarity of the disease. In our immunohistochemical study, proliferative activity of Brunner’s glands was high beneath the epithelium showing gastric foveolar metaplasia. Gastric foveolar metaplasia seems to be a common finding in Brunner’s gland hamartoma [2], and also associated with dysplastic changes in Brunner’s gland hyperplasia [8,9]. One of the duodenal diseases frequently with gastric foveolar metaplasia is duodenal ulcer. In a duodenal ulcer lesion, mucosal repair mechanism initially generates epithelium with gastric foveolar metaplasia and then expands Brunner’s glands [10]. Although how Brunner’s gland hamartoma grows is unclear, it is reasonable to assume that repeated mucosal damages activate mucosal repair mechanism, facilitating a proliferation of Brunner’s glands accompanied by surface gastric foveolar metaplasia. Kim, et al., recently reported histology and mucin expression in Brunner’s gland hamartoma and hyperplasia [2]. They showed that Brunner’s gland hamartoma/hyperplasia lesions tended to be larger with surface epithelial change, such as erosion, ulcer, and gastric foveolar metaplasia, which is in accordance with our hypothesis that mucosal damage facilitates Brunner’s gland proliferation. Although proliferative activity of Brunner’s glands near surface epithelium was not described in their study, slightly increased proliferative activities in atypical glands and sclerotic glandular foci were reported with MIB-1 labeling index of 3% and 2%, respectively. The sclerotic glandular foci are probably old lesions in the mucosal repair process, since the foci were found in 63.2% of the cases with surface epithelial changes but not in the cases without surface epithelial change [2]. Considering possible causes of mucosal damage, mechanical stimuli, Helicobacter pylori infection, and hyperacidic environment in duodenum have been suggested. The latter two have been postulated to be involved in the development of Brunner’s gland hamartoma [11,12]. Helicobacter pylori infection was reported in some cases of Brunner’s gland hamartoma [3], but not observed in the other cases [4]. The infection is unlikely to be essential for a hamartomatous proliferation of Brunner’s glands. Hyperacidity can induce hyperplastic change of Brunner’s glands, which secrete alkaline mucin to buffer gastric acid. Franzin, et al., demonstrated hyperacidic state in patients with Brunner’s gland hamartoma [12]. Interestingly, gastric foveolar metaplasia has been regarded as a protective change of the duodenal mucosa against hyperacidity [13]. In summary, we report a case of large Brunner’s gland hamartoma in a young (26-year-old) patient. Our immunohistochemical results suggest that mucosal damage underlies the hamartomatous proliferation of Brunner’s glands.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Series Editor of this journal.

Abbreviations

MUC: Mucin; HE: Hematoxylin and eosin.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MA collected and analyzed the data, and was involved in drafting the manuscript. ST did clinical aspects of this study including surgical treatment. KH helped designing this study. RK guided us for pathological diagnosis and conception. HK revised the manuscript critically for important intellectual content and supported financially. All authors read and approved of the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-230X/14/14/prepub
  13 in total

1.  Gastrointestinal bleeding from a Brunner's gland hamartoma: characterization by endoscopy, computed tomography, and endoscopic ultrasound.

Authors:  K P Block; T J Frick; T F Warner
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

2.  Histogenesis of gastric foveolar metaplasia following duodenal ulcer: a definite reparative lineage of Brunner's gland.

Authors:  R Kushima; R Manabe; T Hattori; F Borchard
Journal:  Histopathology       Date:  1999-07       Impact factor: 5.087

3.  Acute pancreatitis and upper gastrointestinal bleeding as presenting symptoms of duodenal Brunner's gland hamartoma.

Authors:  Edy Stermer; Nizar Elias; Dean Keren; Tova Rainis; Omer Goldstein; Alexandra Lavy
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

4.  Gastric foveolar metaplasia with dysplastic changes in Brunner gland hyperplasia: possible precursor lesions for Brunner gland adenocarcinoma.

Authors:  Takaki Sakurai; Hiromi Sakashita; Gen Honjo; Ippei Kasyu; Toshiaki Manabe
Journal:  Am J Surg Pathol       Date:  2005-11       Impact factor: 6.394

5.  Gastric-type adenocarcinoma of the duodenal second portion histogenetically associated with hyperplasia and gastric-foveolar metaplasia of Brunner's glands.

Authors:  Ryoji Kushima; Manfred Stolte; Klaus Dirks; Michael Vieth; Hidetoshi Okabe; Franz Borchard; Takanori Hattori
Journal:  Virchows Arch       Date:  2002-02-21       Impact factor: 4.064

6.  Evolution of Brunner gland hamartoma associated with Helicobacter pylori infection.

Authors:  Ravi R Kurella; Hanumantha R Ancha; Sanam Hussain; Stan A Lightfoot; Richard Harty
Journal:  South Med J       Date:  2008-06       Impact factor: 0.954

7.  Clinicopathologic characteristics and mucin expression in Brunner's gland proliferating lesions.

Authors:  Kyungeun Kim; Se Jin Jang; Ho June Song; Eunsil Yu
Journal:  Dig Dis Sci       Date:  2012-07-27       Impact factor: 3.199

8.  Brunner's gland hamartomas: clinical presentation and pathological features of 27 cases.

Authors:  J A Levine; L J Burgart; K P Batts; K K Wang
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

9.  Helicobacter pylori infection in patients with Brunner's gland adenoma.

Authors:  I Kovacević; N Ljubicić; H Cupić; M Doko; M Zovak; B Troskot; M Kujundzić; M Banić
Journal:  Acta Med Croatica       Date:  2001

10.  Nodular hyperplasia of Brunner's glands.

Authors:  G Franzin; R Musola; O Ghidini; C Manfrini; A Fratton
Journal:  Gastrointest Endosc       Date:  1985-12       Impact factor: 9.427

View more
  7 in total

1.  BRUNNER GLAND ADENOMA MASQUERADING AS DUODENAL GASTROINTESTINAL STROMAL TUMOR WITH INTUSSUSCEPTION: CASE REPORT.

Authors:  Gunjan Desai; Kamal Yadav; Prasad Pande; Priyanka Sali; Chandralekha Tampi; Prasad Wagle
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

2.  A 10 cm pedunculated duodenal Brunner gland hamartoma, case report and literature review.

Authors:  Ziyad Alsugair; Pierre Marie Lavrut; Lisa Chassagne
Journal:  Int J Surg Case Rep       Date:  2022-10-17

3.  A Giant Brunneroma Causing Gastrointestinal Bleeding and Severe Anemia Requiring Transfusion and Surgery.

Authors:  Nicola C Frenkel; Miangela M Laclé; Inne H M Borel Rinkes; Izaak Q Molenaar; Jeroen Hagendoorn
Journal:  Case Rep Surg       Date:  2017-02-19

4.  Saving from unnecessary pancreaticoduodenectomy. Brunner's gland hamartoma: Case report on a rare duodenal lesion and exhaustive literature review.

Authors:  Andrea Peloso; Jacopo Viganò; Alessandro Vanoli; Tommaso Dominioni; Sandro Zonta; Dario Bugada; Carlo Maria Bianchi; Francesco Calabrese; Ilaria Benzoni; Marcello Maestri; Paolo Dionigi; Lorenzo Cobianchi
Journal:  Ann Med Surg (Lond)       Date:  2017-03-29

5.  A giant Brunner's gland hamartoma being treated as a pedunculated polyp: a case report.

Authors:  Lizhi Yi; Zhengyu Cheng; Huarong Qiu; Jianjun Yang; Tao Wang; Ke Liu
Journal:  BMC Gastroenterol       Date:  2019-08-23       Impact factor: 3.067

6.  Brunner's Gland Hyperplasias and Hamartomas in Association with Helicobacter pylori.

Authors:  Sabahattin Destek; Vahit Onur Gul
Journal:  Can J Gastroenterol Hepatol       Date:  2019-05-02

Review 7.  Brunner's Gland Hamartoma of the Duodenum: A Literature Review.

Authors:  Menghua Zhu; Hongyu Li; Yanyan Wu; Yang An; Yuye Wang; Chun Ye; Dan Zhang; Rui Ma; Xuehan Wang; Xiaodong Shao; Xiaozhong Guo; Xingshun Qi
Journal:  Adv Ther       Date:  2021-04-29       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.